BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 368476)

  • 1. Evaluation of the activity of streptomycin on Mycobacterium leprae in mice.
    Pattyn SR; Saerens E
    Lepr Rev; 1978 Dec; 49(4):275-81. PubMed ID: 368476
    [No Abstract]   [Full Text] [Related]  

  • 2. Further studies of the killing of M. leprae by aminoglycosides: reduced dosage and frequency of administration.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):78-82. PubMed ID: 3549941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of drugs against Mycobacterium leprae studied in mice.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1972; 40(1):33-9. PubMed ID: 4562383
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined chemotherapy against Mycobacterium leprae in the mouse.
    Pattyn SR; Van Loo G
    Ann Soc Belg Med Trop; 1980 Sep; 60(3):291-5. PubMed ID: 7018423
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening of drugs for activity against Mycobacterium leprae.
    Baohong J; Matsuo Y; Colston MJ
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):836-42. PubMed ID: 3325576
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of antibacterial drugs on the ultrastructure of Mycobacterium leprae in human skin.
    Edwards RP; Draper GJ; Draper P
    Lepr Rev; 1972 Dec; 43(4):173-80. PubMed ID: 4579978
    [No Abstract]   [Full Text] [Related]  

  • 7. The first joint THELEP-Sasakawa Memorial Health Foundation workshop on experimental chemotherapy of leprosy.
    Grosset JH; Baohong J; Ito T
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):807-13. PubMed ID: 3125288
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro and in vivo activities of ofloxacin against Mycobacterium leprae infection induced in mice.
    Saito H; Tomioka H; Nagashima K
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):560-2. PubMed ID: 3546546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of phenazine analogs against Mycobacterium leprae infections in mice.
    Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The killing of Mycobacterium leprae in mice by various dietary concentrations of clofazimine and ethionamide.
    Gelber RH
    Lepr Rev; 1987 Dec; 58(4):407-11. PubMed ID: 3323753
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity of cycloserine and structurally related compounds against M. leprae-infected mice.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):536-8. PubMed ID: 6399071
    [No Abstract]   [Full Text] [Related]  

  • 12. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 13. The activity of rifabutin against Mycobacterium leprae.
    Yoder LJ; Jacobson RR; Hastings RC
    Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
    Pattyn SR; Portaels F; Van Loo G; Van den Breen L
    Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance of Mycobacterium leprae, particularly to DDS.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary observation on the effect of thymic peptide in the experimental infection of mice with mycobacterium leprae].
    Wang HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Jun; 7(3):227-8. PubMed ID: 2939979
    [No Abstract]   [Full Text] [Related]  

  • 17. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of selected beta-lactam antibiotics against Mycobacterium leprae.
    Shepard CC; Van Landingham RM; Walker LL; Good RC
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):322-7. PubMed ID: 3298478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the mouse foot-pad technique in immunologically normal mice in support of clinical drug trials, and a review of earlier clinical drug trials in lepromatous leprosy.
    Levy L
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):823-9. PubMed ID: 3325574
    [No Abstract]   [Full Text] [Related]  

  • 20. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
    Browne SG
    Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.